Cargando…
Serum vascular endothelial growth factor as a tumor marker for hepatocellular carcinoma in hepatitis C virus-related cirrhotic patients
BACKGROUND: Hepatocellular carcinoma (HCC) accounts for 8.2% of all cancer-related deaths worldwide. Being a vascular tumor, vascular endothelial growth factor (VEGF) plays a vital role in HCC pathogenesis, growth, and spread. AIM: To determine the accuracy of serum VEGF and VEGF/platelet (PLT) as t...
Autores principales: | Alzamzamy, Ahmed, Elsayed, Huda, Abd Elraouf, Mona, Eltoukhy, Hanan, Megahed, Tarek, Aboubakr, Ashraf |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8204351/ https://www.ncbi.nlm.nih.gov/pubmed/34163576 http://dx.doi.org/10.4251/wjgo.v13.i6.600 |
Ejemplares similares
-
Competing risk analysis on outcome after hepatic resection of hepatocellular carcinoma in cirrhotic patients
por: Cucchetti, Alessandro, et al.
Publicado: (2017) -
Serum omentin and vaspin levels in cirrhotic patients with and without portal vein thrombosis
por: Kukla, Michał, et al.
Publicado: (2017) -
Bacteremia Caused by a Serotype Ob5 Vibrio cholerae Strain in a Cirrhotic Patient in China
por: Xu, Xiaohong, et al.
Publicado: (2023) -
Prognostic role of plasma level of angiopoietin-1, angiopoietin-2, and vascular endothelial growth factor in hepatocellular carcinoma
por: Choi, Gwang Hyeon, et al.
Publicado: (2021) -
Assessment of fibroblast growth factor 19 as a non-invasive serum marker for hepatocellular carcinoma
por: Mohamed, Ghada Abdelrahman, et al.
Publicado: (2022)